Modification of the adenylate cyclase activity of bovine thyroid plasma membranes by manipulating the ganglioside composition with a nonspecific lipid transfer protein.
Gangliosides (GM1, GT1b, GD3) were incorporated in bovine thyroid plasma membranes using the nonspecific lipid transfer protein from beef liver. The transfer of GT1b or GD3 in the presence of 16 units of transfer protein was twice as high as that of GM1. However, taking into account the spontaneous exchange (approximately 8% for GT1b or GD3 and 1% for GM1) the transfer protein seemed to be more effective for GM1. Incorporation of these gangliosides in bovine thyroid plasma membranes caused a concentration dependent inhibition of the TSH-stimulated adenylate cyclase activity. The forskolin-stimulated adenylate cyclase activity was not significantly affected by ganglioside modification of the plasma membranes, indicating that the gangliosides do not act at the level of the catalyst of adenylate cyclase. Binding experiments on the other hand revealed that TSH binding to bovine thyroid plasma membranes was inhibited with the same order of efficacy (GT1b greater than GD3 greater than GM1) and to the same extent as their inhibitory effect on TSH stimulation. Therefore, this indicates that the ganglioside induced drop in TSH binding might be an important factor in the decrease in TSH-stimulated adenylate cyclase activity. Incorporation of GT1b or GD3 (approximately 11 nmol) in bovine thyroid plasma membranes, however, also induced a substantial decrease in cholera toxin-stimulated adenylate cyclase activity (approximately 30%) and to a lesser degree a decrease in NaF-stimulated activity (approximately 17%), whereas GM1 incorporation did not significantly affect these stimulated activities. These latter inhibitory effects were paralleled by changes in fluorescence steady-state anisotropy: GT1b modification of the plasma membranes provoked a slight increase in TMA-DPH anisotropy, whereas the anisotropy of DPH was substantially enhanced after incorporation of GD3 or GT1b. These results suggest that gangliosides might also interfere with the coupling between the alpha-subunit of the stimulatory GTP-binding regulatory protein and the catalyst of the adenylate cyclase system by affecting the membrane fluidity.
Depauw
H
H
RUCA-Laboratory for Human Biochemistry, University of Antwerp, Belgium.
De Wolf
M
M
Van Dessel
G
G
Lagrou
A
A
Hilderson
H J
HJ
Dierick
W
W
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002352:Carrier Proteins; D002417:Cattle; D002772:Cholera Toxin / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D005454:Fluorescence Polarization; D005732:Gangliosides / Q000502:physiology*; D066298:In Vitro Techniques; D008560:Membrane Fluidity; D008563:Membrane Lipids / Q000502:physiology*; D011989:Receptors, Thyrotropin / Q000378:metabolism; D012969:Sodium Fluoride / Q000494:pharmacology; D013696:Temperature; D013961:Thyroid Gland / Q000201:enzymology*; D013972:Thyrotropin / Q000378:metabolism / Q000494:pharmacology
D002352:Carrier Proteins; D005732:Gangliosides; D008563:Membrane Lipids; D011989:Receptors, Thyrotropin; C030363:lipid transfer protein; D005576:Colforsin; D012969:Sodium Fluoride; D013972:Thyrotropin; D002772:Cholera Toxin; D000262:Adenylyl Cyclases